Evidence map›Paper›PMID 40225912›Full record

ArticleHuman mutation2024

Ainhoa Escuela-Escobar, Esther Herrera-Luis, Elena Martín-González, José María Hernández-Pérez, Mario A González Carracedo, José Antonio Pérez Pérez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human mutation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ainhoa Escuela-EscobarGenomics and Health Group Department of Biochemistry Microbiology Cell Biology and Genetics Universidad de La Laguna (ULL), 38200 La Laguna, Tenerife, Spain.ORCID 0009-0002-8517-161X
Esther Herrera-LuisDepartment of Epidemiology Bloomberg School of Public Health Johns Hopkins University, Baltimore, Maryland, USA.
Elena Martín-GonzálezGenomics and Health Group Department of Biochemistry Microbiology Cell Biology and Genetics Universidad de La Laguna (ULL), 38200 La Laguna, Tenerife, Spain.
José María Hernández-PérezDepartment of Respiratory Medicine Hospital Universitario de N. S de Candelaria (HUNSC), 38010 Santa Cruz de Tenerife, Tenerife, Spain.
Mario A González CarracedoGenomics and Health Group Department of Biochemistry Microbiology Cell Biology and Genetics Universidad de La Laguna (ULL), 38200 La Laguna, Tenerife, Spain.ORCID 0000-0003-1386-0571
José Antonio Pérez PérezGenomics and Health Group Department of Biochemistry Microbiology Cell Biology and Genetics Universidad de La Laguna (ULL), 38200 La Laguna, Tenerife, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder caused by specific variants in the

Indexed as

Allelesalpha 1-Antitrypsinalpha 1-Antitrypsin DeficiencyCell Cycle ProteinsEnhancer Elements, GeneticTranscription FactorsBromodomain Containing ProteinsFemaleGenetic Predisposition to DiseaseGenotypeHumansInfant, NewbornMalePolymorphism, Single Nucleotidealpha 1-AntitrypsinBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsSERPINA1 protein, humanTranscription FactorsAlpha-1 antitrypsinBRD4-Independent EnhancerCpGPi∗SPi∗ZSERPINA1

Identifiers

PMID40225912
PMCPMC11924960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.